Imagen de perfil
Chris@Multibagger
9Lun
Apart from $GSIT, I have them all.
•
1
•
Imagen de perfil
Darkwingduck@Darkwingduck
9Lun
@Multibagger nectar, I'm really excited. It's almost an all or nothing bet. If the 52-week study disappoints, you have to win the lawsuit against Eli Lilly for a second Versuch😵‍💫 but I'm in good spirits
•
1
•
Imagen de perfil
Chris@Multibagger
9Lun
@Darkwingduck I think it will at least double this year.
••
Imagen de perfil
Darkwingduck@Darkwingduck
9Lun
@Multibagger If the study is good, then Lutzi will really take off. They will then enter markets worth several billion euros (Dupixent, Rinvoq).
•
1
•
Imagen de perfil
Darkwingduck@Darkwingduck
9Lun
@Multibagger Have you heard of $LCTX? They've partnered with Roche $ROG for their studies.
•
1
•
Imagen de perfil
Chris@Multibagger
9Lun
@Darkwingduck never heard
••